UB Paderborn / Katalog / Suche / in CDI

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Journal for immunotherapy of cancer, 2019-02, Vol.7 (1), p.38-14, Article 38

2019

Link zum Volltext

Verfügbarkeit prüfen

Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats

Vaccines (Basel), 2024-05, Vol.12 (5), p.490

2024

Link zum Volltext

Verfügbarkeit prüfen

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

CPT: pharmacometrics and systems pharmacology, 2018-04, Vol.7 (4), p.228-236

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway

Kidney international, 2001-07, Vol.60 (1), p.83-86

2001

Link zum Volltext

Verfügbarkeit prüfen

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

The Journal of pharmacology and experimental therapeutics, 2002-03, Vol.300 (3), p.952

2002

Link zum Volltext

Verfügbarkeit prüfen

Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function?

Seminars in thrombosis and hemostasis, 2005-08, Vol.31 (4), p.400-403

2005

Link zum Volltext

Verfügbarkeit prüfen

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations

Clinical pharmacokinetics, 2004, Vol.43 (14), p.963-981

2004

Link zum Volltext

Verfügbarkeit prüfen

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

Journal of clinical pharmacology, 2011-06, Vol.51 (6), p.805-818

2011

Link zum Volltext

Verfügbarkeit prüfen

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Biomicrofluidics, 2013-09, Vol.7 (5), p.56502-56502

2013

Link zum Volltext

Verfügbarkeit prüfen

408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A248-A248

2020

Link zum Volltext

Verfügbarkeit prüfen

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

Platelets (Edinburgh), 2015-02, Vol.26 (1), p.59-66

2015

Link zum Volltext

Verfügbarkeit prüfen

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

Journal of thoracic oncology, 2017-01, Vol.12 (1), p.S1333-S1334

2017

Link zum Volltext

Verfügbarkeit prüfen

Flow cytometric measurement of platelet- leukocyte aggregates : A possible target to monitor platelet function?: Reliability of platelet function tests and drug monitoring

Seminars in thrombosis and hemostasis, 2005, Vol.31 (4), p.400-403

2005

Link zum Volltext

Verfügbarkeit prüfen

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Journal of antimicrobial chemotherapy, 2008-11, Vol.62 (5), p.1118-1121

2008

Link zum Volltext

Verfügbarkeit prüfen

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or anti-platelet therapy: pharmacokinetic and pharmacodynamic considerations

Clinical pharmacokinetics, 2004-12, Vol.43 (14), p.963

2004

Link zum Volltext

Verfügbarkeit prüfen

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

Thrombosis research, 2003, Vol.111 (4-5), p.251-257

2003

Link zum Volltext

Verfügbarkeit prüfen

A novel ?-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Biomicrofluidics, 2013-01, Vol.7 (5)

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet–leukocyte aggregates

Thrombosis research, 2003, Vol.111 (4), p.251-257

2003

Link zum Volltext

Verfügbarkeit prüfen

Thrombolytics : Drug interactions of clinical significance

Drug safety, 2000-11, Vol.23 (5), p.391-399

2000

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans

British journal of clinical pharmacology, 2003-09, Vol.56 (3), p.321-326

2003

Link zum Volltext

Verfügbarkeit prüfen

Dosis-Wirkungs-Beziehung: Relevanz für die ärztliche Praxis

Medizinische Klinik (München. 1983), 1998-12, Vol.93 (12), p.744-749

1998

Link zum Volltext

Verfügbarkeit prüfen

Role of the retention test homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs: Reliability of platelet function tests and drug monitoring

Seminars in thrombosis and hemostasis, 2005, Vol.31 (4), p.458-463

2005

Link zum Volltext

Verfügbarkeit prüfen

Adhesion, spreading, and aggregation of platelets in flowing blood and the reliability of the retention test homburg: Reliability of platelet function tests and drug monitoring

Seminars in thrombosis and hemostasis, 2005, Vol.31 (4), p.449-457

2005

Link zum Volltext

Verfügbarkeit prüfen

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

British journal of clinical pharmacology, 2001-09, Vol.52 (3), p.297-305

2001

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849 (CV9202), combined with local radiation treatment in patients with stage IV non-small cell lung cancer

Novel Multi-Antigen Orf-Virus-Derived Vaccine Elicits Protective Anti-SARS-CoV-2 Response in Monovalent and Bivalent Formats

Assessing Similarity Among Individual Tumor Size Lesion Dynamics: The CICIL Methodology

Angiotensin II infusion increases plasma erythropoietin levels via an angiotensin II type 1 receptor-dependent pathway

Close relationship between the platelet activation marker CD62 and the granular release of platelet-derived growth factor

Flow Cytometric Measurement of Platelet-Leukocyte Aggregates: A Possible Target to Monitor Platelet Function?

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or antiplatelet therapy: Pharmacokinetic and pharmacodynamic considerations

Anticoagulation With Argatroban for Elective Percutaneous Coronary Intervention: Population Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Relationship of Coagulation Parameters

A novel μ-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

408 Phase I, first-in-human trial evaluating BI 1387446 (stimulator of interferon genes [STING] agonist) alone and combined with BI 754091 (anti-programmed cell death [PD]-1) in solid tumors

The integrin antagonist, cilengitide, is a weak inhibitor of αIIbβ3 mediated platelet activation and inhibits platelet adhesion under flow

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC: Topic: IT Clinical

P3.02c-091 Final Phase Ib Results of RNActive® Cancer Vaccine BI 1361849 and Local Radiation as Maintenance Therapy for Stage IV NSCLC

Flow cytometric measurement of platelet- leukocyte aggregates : A possible target to monitor platelet function?: Reliability of platelet function tests and drug monitoring

Platelet–leucocyte adhesion markers before and after the initiation of antiretroviral therapy with HIV protease inhibitors

Avoidance of bleeding during surgery in patients receiving anticoagulant and/or anti-platelet therapy: pharmacokinetic and pharmacodynamic considerations

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet-leukocyte aggregates

A novel ?-fluidic whole blood coagulation assay based on Rayleigh surface-acoustic waves as a point-of-care method to detect anticoagulants

Effects of the NHE-1 inhibitor cariporide alone or together with the P2Y 12 antagonist AR-C 69331 MX on CD62p expression and formation of platelet–leukocyte aggregates

Thrombolytics : Drug interactions of clinical significance

Pharmacodynamic characterization of the interaction between the glycoprotein IIb/IIIa inhibitor YM337 and unfractionated heparin and aspirin in humans

Dosis-Wirkungs-Beziehung: Relevanz für die ärztliche Praxis

Role of the retention test homburg in evaluating platelet hyperactivity and in monitoring therapy with antiplatelet drugs: Reliability of platelet function tests and drug monitoring

Adhesion, spreading, and aggregation of platelets in flowing blood and the reliability of the retention test homburg: Reliability of platelet function tests and drug monitoring

Pharmacodynamic characterization of the interaction between abciximab or tirofiban with unfractionated or a low molecular weight heparin in healthy subjects

Aktive Filter

Suchergebnisse filtern